Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10287312
Cyclic peroxides as prodrugs for selective delivery of agents
granted -
US 10287305
Substituted piperidine compound and use thereof
granted -
US 10287262
Eicosanoid derivatives
granted -
US 10287279
Inhibitors of human 12/15-lipoxygenase
granted -
US 10286077
Steroid hormone compositions in medium chain oils
granted -
US 10286072
Methods of manufacturing stable aqueous formulations of adalimumab
granted -
US 10286071
Syringe containing stable aqueous formulations of adalimumab
granted -
US 10286065
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
granted -
US 10286054
Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium difficil associated disease (CDAD)
granted -
US 10286044
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
granted -
US 10287286
Compounds
granted -
US 10286012
Compositions and methods for transplantation of colon microbiota
granted -
US 10286038
Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
granted -
US 10286031
Method of manufacture of GnRH-containing gel
granted -
US 10286016
Compositions and methods for treating gonorrhea
granted -
US 10286036
Protocol for treatment of lupus nephritis
granted -
US 10285986
Compounds and anti-tumor NQO1 substrates
granted -
US 10285996
Compositions comprising triterpenoids
granted -
US 10285978
Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio
granted -
US 10285964
Fatty-acid based particles
granted -
US 10285962
Glutarate compounds for treating ischemia-reperfusion injuries
granted -
US 10285945
Formation of stable submicron peptide or protein particles by thin film freezing
granted -
US 10285956
N-(2-aminoethyl) ethanolamine (AEEA) and analogs to treat hypertrophic scarring and liposomal topical delivery
granted -
US 10285952
Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.